Figure 3. Patient screening flow chart.
From 1,080 patients studied for KIT/PDGFRA mutations, 185 were KIT/PDGFRA wild-type and 146 were analyzed using targeted next-generation sequencing (NGS). There was insufficient genomic DNA or the library preparation failed for 39 patients.